Melissa Jarrell
Executive Director of Legal
Replay available
Heron Therapeutics, Inc. (NASDAQ: HRTX) Q4 2025 earnings conference call, held 2026-02-26. Replay captured from the company's public earnings webcast.

Executive Director of Legal
Investor Relations Host
Chief Executive Officer
Chief Operating Officer
Executive Vice President, Chief Financial Officer
Senior Vice President, Medical Affairs, Strategy, and Engagement
Analyst, Needham & Company
Analyst, A.C. Wainwright & Co.
Watch the replay and follow the connected company analysis, news, and investor updates for Heron Therapeutics, Inc..
WEBVTT 00:00:00.166 -- 00:00:06.031 Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 00:00:06.031 -- 00:00:10.095 conference call. At this time, all participants are in a listen-only mode. 00:00:10.095 -- 00:00:14.339 After the speaker's presentation, there will be a question and answer session. 00:00:14.339 -- 00:00:18.482 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:18.482 -- 00:00:22.306 You will then hear an automated message advising your hand is raised. 00:00:22.306 -- 00:00:24.848 To withdraw your question, please press star 1-1 again. 00:00:24.848 -- 00:00:28.516 Please be advised that today's conference is being recorded. 00:00:28.516 -- 00:00:32.181 I would now like to hand the conference over to your first speaker today, Melissa Jarrell, 00:00:32.181 -- 00:00:33.823 Executive Director of Legal. 00:00:33.823 -- 00:00:36.364 Please go ahead. 00:00:40.312 -- 00:00:42.655 Thank you, Operator, and hello, everyone. 00:00:42.655 -- 00:00:46.521 Thank you for joining us on the Heron Therapeutics conference call today to discuss the 00:00:46.521 -- 00:00:51.868 company's financial results for the fourth quarter and year ended December 31st, 2025. 00:00:51.868 -- 00:00:56.675 With me today from Heron are Craig Collard, Chief Executive Officer, Dara Duarte, Executive 00:00:56.675 -- 00:01:00.747 Vice President, Chief Financial Officer, Bill Forbes, Executive Vice President, Chief 00:01:00.747 -- 00:01:05.714 Development Officer, Mark Hensley, Chief Operating Officer, and Kevin Warner, Senior 00:01:05.714 -- 00:01:09.219 Vice President, Medical Affairs, Strategy, and Engagement. 00:01:09.219 -- 00:01:13.885 For those of you participating via conference call, slides are made available v...